APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nimodipine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nimodipine Industry Growth and Trends Forecast to 2032

Report ID 174017080120 December 2025107 pages

Choose your research edition.

Industry ResearchNimodipine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Nimodipine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nimodipine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nimodipine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nimodipine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Nimodipine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nimodipine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nimodipine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nimodipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nimodipine include Yangtze River Pharmaceutical, Shandong Xinhua Pharmaceutical, Sichuan Kelun Pharmaceutical, Hubei Jumpcan Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Cisen Pharmaceutical, Bayer, Bionpharma and Azurity, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nimodipine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nimodipine market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nimodipine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nimodipine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nimodipine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nimodipine Market by Company

Yangtze River Pharmaceutical

Shandong Xinhua Pharmaceutical

Sichuan Kelun Pharmaceutical

Hubei Jumpcan Pharmaceutical

Jiangsu Hengrui Pharmaceuticals

Cisen Pharmaceutical

Bayer

Bionpharma

Azurity

Avet Pharmaceuticals Inc.

Nimodipine Segment by Type

Solution

Tablets

Capsule

Nimodipine Segment by Application

Clinics

Hospital

Pharmacy

Others

Nimodipine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nimodipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nimodipine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nimodipine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nimodipine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nimodipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Solution Table 2. Major Company of Tablets Table 3. Major Company of Capsule Table 4. Global Nimodipine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nimodipine Sales by Type (2021-2026) & (tons) Table 6. Global Nimodipine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nimodipine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nimodipine Sales Market Share in Value by Type (2021-2026) Table 9. Global Nimodipine Price by Type (2021-2026) & (US$/kg) Table 10. Global Nimodipine Sales by Type (2027-2032) & (tons) Table 11. Global Nimodipine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nimodipine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nimodipine Sales Market Share in Value by Type (2027-2032) Table 14. Global Nimodipine Price by Type (2027-2032) & (US$/kg) Table 15. North America Nimodipine Sales by Type (2021-2026) & (tons) Table 16. North America Nimodipine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nimodipine Sales by Type (2021-2026) & (tons) Table 18. Europe Nimodipine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nimodipine Sales by Type (2021-2026) & (tons) Table 20. Asia-Pacific Nimodipine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nimodipine Sales by Type (2021-2026) & (tons) Table 22. Latin America Nimodipine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nimodipine Sales by Type (2021-2026) & (tons) Table 24. Middle East and Africa Nimodipine Sales by Type (2021-2026) & (US$ Million) Table 25. Nimodipine Industry Trends Table 26. Nimodipine Industry Drivers Table 27. Nimodipine Industry Opportunities and Challenges Table 28. Nimodipine Industry Restraints Table 29. Global Nimodipine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nimodipine Revenue Market Share by Company (2021-2026) Table 31. Global Nimodipine Sales by Company (2021-2026) & (tons) Table 32. Global Nimodipine Sales Share by Company (2021-2026) Table 33. Global Nimodipine Market Price by Company (2021-2026) & (US$/kg) Table 34. Global Nimodipine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nimodipine Major Company Production Sites and Headquarters Table 36. Global Nimodipine Company, Product Type & Application Table 37. Global Nimodipine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nimodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nimodipine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nimodipine Sales by Region (2021-2026) & (tons) Table 42. Global Nimodipine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nimodipine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nimodipine Sales Market Share in Value by Region (2021-2026) Table 45. Global Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 46. Global Nimodipine Sales by Region (2027-2032) & (tons) Table 47. Global Nimodipine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nimodipine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nimodipine Sales Market Share in Value by Region (2027-2032) Table 50. Global Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 51. Global Nimodipine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nimodipine Sales by Application (2021-2026) & (tons) Table 53. Global Nimodipine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nimodipine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nimodipine Sales Market Share in Value by Application (2021-2026) Table 56. Global Nimodipine Price by Application (2021-2026) & (US$/kg) Table 57. Global Nimodipine Sales by Application (2027-2032) & (tons) Table 58. Global Nimodipine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nimodipine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nimodipine Sales Market Share in Value by Application (2027-2032) Table 61. Global Nimodipine Price by Application (2027-2032) & (US$/kg) Table 62. North America Nimodipine Sales by Application (2021-2026) & (tons) Table 63. North America Nimodipine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nimodipine Sales by Application (2021-2026) & (tons) Table 65. Europe Nimodipine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nimodipine Sales by Application (2021-2026) & (tons) Table 67. Asia-Pacific Nimodipine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nimodipine Sales by Application (2021-2026) & (tons) Table 69. Latin America Nimodipine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nimodipine Sales by Application (2021-2026) & (tons) Table 71. Middle East and Africa Nimodipine Sales by Application (2021-2026) & (US$ Million) Table 72. Yangtze River Pharmaceutical Company Information Table 73. Yangtze River Pharmaceutical Business Overview Table 74. Yangtze River Pharmaceutical Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Yangtze River Pharmaceutical Nimodipine Product Portfolio Table 76. Yangtze River Pharmaceutical Recent Development Table 77. Shandong Xinhua Pharmaceutical Company Information Table 78. Shandong Xinhua Pharmaceutical Business Overview Table 79. Shandong Xinhua Pharmaceutical Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. Shandong Xinhua Pharmaceutical Nimodipine Product Portfolio Table 81. Shandong Xinhua Pharmaceutical Recent Development Table 82. Sichuan Kelun Pharmaceutical Company Information Table 83. Sichuan Kelun Pharmaceutical Business Overview Table 84. Sichuan Kelun Pharmaceutical Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Sichuan Kelun Pharmaceutical Nimodipine Product Portfolio Table 86. Sichuan Kelun Pharmaceutical Recent Development Table 87. Hubei Jumpcan Pharmaceutical Company Information Table 88. Hubei Jumpcan Pharmaceutical Business Overview Table 89. Hubei Jumpcan Pharmaceutical Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Hubei Jumpcan Pharmaceutical Nimodipine Product Portfolio Table 91. Hubei Jumpcan Pharmaceutical Recent Development Table 92. Jiangsu Hengrui Pharmaceuticals Company Information Table 93. Jiangsu Hengrui Pharmaceuticals Business Overview Table 94. Jiangsu Hengrui Pharmaceuticals Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Jiangsu Hengrui Pharmaceuticals Nimodipine Product Portfolio Table 96. Jiangsu Hengrui Pharmaceuticals Recent Development Table 97. Cisen Pharmaceutical Company Information Table 98. Cisen Pharmaceutical Business Overview Table 99. Cisen Pharmaceutical Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. Cisen Pharmaceutical Nimodipine Product Portfolio Table 101. Cisen Pharmaceutical Recent Development Table 102. Bayer Company Information Table 103. Bayer Business Overview Table 104. Bayer Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 105. Bayer Nimodipine Product Portfolio Table 106. Bayer Recent Development Table 107. Bionpharma Company Information Table 108. Bionpharma Business Overview Table 109. Bionpharma Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 110. Bionpharma Nimodipine Product Portfolio Table 111. Bionpharma Recent Development Table 112. Azurity Company Information Table 113. Azurity Business Overview Table 114. Azurity Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 115. Azurity Nimodipine Product Portfolio Table 116. Azurity Recent Development Table 117. Avet Pharmaceuticals Inc. Company Information Table 118. Avet Pharmaceuticals Inc. Business Overview Table 119. Avet Pharmaceuticals Inc. Nimodipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 120. Avet Pharmaceuticals Inc. Nimodipine Product Portfolio Table 121. Avet Pharmaceuticals Inc. Recent Development Table 122. North America Nimodipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 123. North America Nimodipine Sales by Country (2021-2026) & (tons) Table 124. North America Nimodipine Sales Market Share by Country (2021-2026) Table 125. North America Nimodipine Sales Forecast by Country (2027-2032) & (tons) Table 126. North America Nimodipine Sales Market Share Forecast by Country (2027-2032) Table 127. North America Nimodipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Nimodipine Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Nimodipine Market Share by Country (2021-2026) Table 130. North America Nimodipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Nimodipine Market Share Forecast by Country (2027-2032) Table 132. Europe Nimodipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 133. Europe Nimodipine Sales by Country (2021-2026) & (tons) Table 134. Europe Nimodipine Sales Market Share by Country (2021-2026) Table 135. Europe Nimodipine Sales Forecast by Country (2027-2032) & (tons) Table 136. Europe Nimodipine Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Nimodipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Nimodipine Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Nimodipine Market Share by Country (2021-2026) Table 140. Europe Nimodipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Nimodipine Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Nimodipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Nimodipine Sales by Country (2021-2026) & (tons) Table 144. Asia-Pacific Nimodipine Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Nimodipine Sales Forecast by Country (2027-2032) & (tons) Table 146. Asia-Pacific Nimodipine Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Nimodipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Nimodipine Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Nimodipine Market Share by Country (2021-2026) Table 150. Asia-Pacific Nimodipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Nimodipine Market Share Forecast by Country (2027-2032) Table 152. Latin America Nimodipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 153. Latin America Nimodipine Sales by Country (2021-2026) & (tons) Table 154. Latin America Nimodipine Sales Market Share by Country (2021-2026) Table 155. Latin America Nimodipine Sales Forecast by Country (2027-2032) & (tons) Table 156. Latin America Nimodipine Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Nimodipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Nimodipine Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Nimodipine Market Share by Country (2021-2026) Table 160. Latin America Nimodipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Nimodipine Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Nimodipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Nimodipine Sales by Country (2021-2026) & (tons) Table 164. Middle East and Africa Nimodipine Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Nimodipine Sales Forecast by Country (2027-2032) & (tons) Table 166. Middle East and Africa Nimodipine Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Nimodipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Nimodipine Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Nimodipine Market Share by Country (2021-2026) Table 170. Middle East and Africa Nimodipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Nimodipine Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Nimodipine Distributors List Table 175. Nimodipine Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Nimodipine Image Figure 2. Global Nimodipine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nimodipine Market Size (2021-2032) & (US$ Million) Figure 4. Global Nimodipine Sales (2021-2032) & (tons) Figure 5. Solution Image Figure 6. Global Solution Sales YoY Growth (2021-2032) & (tons) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (tons) Figure 9. Capsule Image Figure 10. Global Capsule Sales YoY Growth (2021-2032) & (tons) Figure 11. Global Nimodipine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nimodipine Market Share by Type 2025 VS 2032 Figure 13. North America Nimodipine Sales Market Share in Volume by Type in 2025 Figure 14. North America Nimodipine Sales Market Share in Value by Type in 2025 Figure 15. Europe Nimodipine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nimodipine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nimodipine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nimodipine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nimodipine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nimodipine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nimodipine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nimodipine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nimodipine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (tons) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (tons) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 33. Global Nimodipine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Nimodipine Market Share by Application 2025 VS 2032 Figure 35. North America Nimodipine Sales Market Share in Volume by Application in 2025 Figure 36. North America Nimodipine Sales Market Share in Value by Application in 2025 Figure 37. Europe Nimodipine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Nimodipine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Nimodipine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Nimodipine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Nimodipine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Nimodipine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Nimodipine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Nimodipine Sales Market Share in Value by Application in 2025 Figure 45. North America Nimodipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. North America Nimodipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Nimodipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Nimodipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nimodipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Europe Nimodipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nimodipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Nimodipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nimodipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Asia-Pacific Nimodipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Nimodipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Nimodipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nimodipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Latin America Nimodipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Nimodipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Nimodipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nimodipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 62. Middle East and Africa Nimodipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Nimodipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Nimodipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Nimodipine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Nimodipine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Tablets
  • Capsule
Applications
  • Clinics
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Yangtze River Pharmaceutical
  • Shandong Xinhua Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Hubei Jumpcan Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Cisen Pharmaceutical
  • Bayer
  • Bionpharma
  • Azurity
  • Avet Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nimodipine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nimodipine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nimodipine Market by Type
  6. 1.3.1 Solution
  7. 1.3.2 Tablets
  8. 1.3.3 Capsule
  9. 1.4 Global Nimodipine Market Size by Type
  10. 1.4.1 Global Nimodipine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nimodipine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nimodipine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nimodipine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nimodipine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nimodipine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nimodipine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nimodipine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nimodipine Industry Trends
  2. 2.2 Nimodipine Industry Drivers
  3. 2.3 Nimodipine Industry Opportunities and Challenges
  4. 2.4 Nimodipine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nimodipine Revenue (2021-2026)
  2. 3.2 Global Top Players by Nimodipine Sales (2021-2026)
  3. 3.3 Global Top Players by Nimodipine Price (2021-2026)
  4. 3.4 Global Nimodipine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nimodipine Major Company Production Sites & Headquarters
  6. 3.6 Global Nimodipine Company, Product Type & Application
  7. 3.7 Global Nimodipine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nimodipine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nimodipine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nimodipine Tier 1, Tier 2, and Tier 3
4 Nimodipine Regional Status and Outlook
  1. 4.1 Global Nimodipine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nimodipine Historic Market Size by Region
  3. 4.2.1 Global Nimodipine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nimodipine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nimodipine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nimodipine Forecasted Market Size by Region
  7. 4.3.1 Global Nimodipine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nimodipine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nimodipine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nimodipine by Application
  1. 5.1 Nimodipine Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Nimodipine Market Size by Application
  7. 5.2.1 Global Nimodipine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Nimodipine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Nimodipine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Nimodipine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Nimodipine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Nimodipine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Nimodipine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Nimodipine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yangtze River Pharmaceutical
  2. 6.1.1 Yangtze River Pharmaceutical Company Information
  3. 6.1.2 Yangtze River Pharmaceutical Business Overview
  4. 6.1.3 Yangtze River Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yangtze River Pharmaceutical Nimodipine Product Portfolio
  6. 6.1.5 Yangtze River Pharmaceutical Recent Developments
  7. 6.2 Shandong Xinhua Pharmaceutical
  8. 6.2.1 Shandong Xinhua Pharmaceutical Company Information
  9. 6.2.2 Shandong Xinhua Pharmaceutical Business Overview
  10. 6.2.3 Shandong Xinhua Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shandong Xinhua Pharmaceutical Nimodipine Product Portfolio
  12. 6.2.5 Shandong Xinhua Pharmaceutical Recent Developments
  13. 6.3 Sichuan Kelun Pharmaceutical
  14. 6.3.1 Sichuan Kelun Pharmaceutical Company Information
  15. 6.3.2 Sichuan Kelun Pharmaceutical Business Overview
  16. 6.3.3 Sichuan Kelun Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sichuan Kelun Pharmaceutical Nimodipine Product Portfolio
  18. 6.3.5 Sichuan Kelun Pharmaceutical Recent Developments
  19. 6.4 Hubei Jumpcan Pharmaceutical
  20. 6.4.1 Hubei Jumpcan Pharmaceutical Company Information
  21. 6.4.2 Hubei Jumpcan Pharmaceutical Business Overview
  22. 6.4.3 Hubei Jumpcan Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hubei Jumpcan Pharmaceutical Nimodipine Product Portfolio
  24. 6.4.5 Hubei Jumpcan Pharmaceutical Recent Developments
  25. 6.5 Jiangsu Hengrui Pharmaceuticals
  26. 6.5.1 Jiangsu Hengrui Pharmaceuticals Company Information
  27. 6.5.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  28. 6.5.3 Jiangsu Hengrui Pharmaceuticals Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jiangsu Hengrui Pharmaceuticals Nimodipine Product Portfolio
  30. 6.5.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  31. 6.6 Cisen Pharmaceutical
  32. 6.6.1 Cisen Pharmaceutical Company Information
  33. 6.6.2 Cisen Pharmaceutical Business Overview
  34. 6.6.3 Cisen Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cisen Pharmaceutical Nimodipine Product Portfolio
  36. 6.6.5 Cisen Pharmaceutical Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Nimodipine Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 Bionpharma
  44. 6.8.1 Bionpharma Company Information
  45. 6.8.2 Bionpharma Business Overview
  46. 6.8.3 Bionpharma Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bionpharma Nimodipine Product Portfolio
  48. 6.8.5 Bionpharma Recent Developments
  49. 6.9 Azurity
  50. 6.9.1 Azurity Company Information
  51. 6.9.2 Azurity Business Overview
  52. 6.9.3 Azurity Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Azurity Nimodipine Product Portfolio
  54. 6.9.5 Azurity Recent Developments
  55. 6.10 Avet Pharmaceuticals Inc.
  56. 6.10.1 Avet Pharmaceuticals Inc. Company Information
  57. 6.10.2 Avet Pharmaceuticals Inc. Business Overview
  58. 6.10.3 Avet Pharmaceuticals Inc. Nimodipine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Avet Pharmaceuticals Inc. Nimodipine Product Portfolio
  60. 6.10.5 Avet Pharmaceuticals Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Nimodipine Sales by Country
  2. 7.1.1 North America Nimodipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nimodipine Sales by Country (2021-2026)
  4. 7.1.3 North America Nimodipine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nimodipine Market Size by Country
  6. 7.2.1 North America Nimodipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nimodipine Market Size by Country (2021-2026)
  8. 7.2.3 North America Nimodipine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nimodipine Sales by Country
  2. 8.1.1 Europe Nimodipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nimodipine Sales by Country (2021-2026)
  4. 8.1.3 Europe Nimodipine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nimodipine Market Size by Country
  6. 8.2.1 Europe Nimodipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nimodipine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nimodipine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nimodipine Sales by Country
  2. 9.1.1 Asia-Pacific Nimodipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nimodipine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nimodipine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nimodipine Market Size by Country
  6. 9.2.1 Asia-Pacific Nimodipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nimodipine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nimodipine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nimodipine Sales by Country
  2. 10.1.1 South America Nimodipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nimodipine Sales by Country (2021-2026)
  4. 10.1.3 South America Nimodipine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nimodipine Market Size by Country
  6. 10.2.1 South America Nimodipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nimodipine Market Size by Country (2021-2026)
  8. 10.2.3 South America Nimodipine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nimodipine Sales by Country
  2. 11.1.1 Middle East and Africa Nimodipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nimodipine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nimodipine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nimodipine Market Size by Country
  6. 11.2.1 Middle East and Africa Nimodipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nimodipine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nimodipine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nimodipine Value Chain Analysis
  2. 12.1.1 Nimodipine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nimodipine Production Mode & Process
  7. 12.2 Nimodipine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nimodipine Distributors
  10. 12.2.3 Nimodipine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst